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Coronavirus disease 2019 (CoViD-19) pandemic is strongly impacting all domains of our 
healthcare systems, including rehabilitation. In Italy, the first hit European country, medical 
activities were postponed to allow shifting of staff and facilities to intensive care, with 
neurorehabilitation limited to time-dependent diseases,1 including CoViD-19 complications.2,3 
Hospital access to people with chronic neurodegenerative conditions such as multiple sclerosis, 
movement disorders or dementia, more at risks of serious consequences from the infection,4 has 
been postponed. Patients also seek less for hospital care, with over 50% reduced stroke 
admissions as from an Italian survey,5 possibly in fear of being infected or denied to see their 
families after being hospitalized. This situation can be bearable only for a short time, as any initial 
freezing reaction to a danger. 
After about two months from the first European national lockdown, in Italy (March 10), it has 
become evident that COVID-19 will be still circulating for the next months, until the epidemic will 
become self-limited, or effective vaccines will become available. We need to take specific actions 
and adaptive strategies to at least grant a restoration of the previous level of healthcare 
activities, safely. Neurorehabilitation for CoViD-19 patients should also begin in the intensive 
care unit, fostering recovery and weaning and allowing to improve their prognosis, admitting the 
right patient in the right moment in their recovery pathway. Neurorehabilitation cannot be 
further delayed even to people with disabilities from chronic progressive diseases, requiring 
constant monitoring and care.
With the re-opening of productive activities, we are facing increased neurorehabilitation needs, 
not only as a consequence of prolonged immobilization and acute neurological complications 
from COVID-19, but also of mitigation healthcare and civil measures (e.g. reduction of physical 
activity from government decrees, postponing already scheduled medical interventions, reduced 
management of medical conditions with expected increased incidence of complications, e.g. 
cardiovascular).2–4
Telerehabilitation platforms for physical, language and cognitive rehabilitation, exergaming, 
allowing remote supervision and collection of patient-reported outcomes,6 should be offered, 
including personnel training, also keeping in mind their drawbacks (Table 1). Some clinical events, 
disease progression or treatment side effects can go undetected. Severely disabling symptoms as 
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(computers, iPads or virtual reality 3D visors), without any physical intervention. Robotic-based 
and exoskeleton interventions will need to be implemented more efficiently,7 not only for 
rehabilitation centers to limit patient-physiotherapist interactions, but also for at-home use to 
limit risks from traveling and patient-to-patient proximity. Neurorehabilitation centers will need 
to consider SARS-CoV-2 screening, searching for fever or respiratory symptoms, and performing 
oro-pharyngeal swabs and/or serologic tests to identify asymptomatic individuals according to 
local regulations.8
Physical distancing, separate pathways for CoViD-19 positive and negative patients, and 
adequate personal protection equipment (PPE) will continue.
Rehabilitation facilities will need to offer larger common spaces, or reduced patients’ 
simultaneous occupancy with longer waiting lists and/or longer opening hours, also to allow 
sanitization of medical equipment and common areas multiple times per day.
Forbidding access to visitors or strongly limiting their access to hospitals not only has had a 
terrible psychological impact on severely ill patients,9 but is going to limit the occasions for 
fruitful interactions among patients, caregivers and operators in rehabilitation settings. PPE, such 
as surgical or FFP2/FFP3 masks, gloves, protective gowns, goggles and/or face shields, should be 
considered in light of the national/local recommendations. Wearing a mask may be cumbersome 
for disabled patients, particularly during effortful physical activities. Masks may also limit specific 
interventions, such as logopedic exercises requiring imitation of the operator. Again, technology 
may help, but may not be enough. CoViD-19 pandemic is also stealing away our faces as means 
of emotional communication and empathy, so relevant in the process of healing. We must 
further explore protections alternative to masks, like face shields or transparent panels, 
proposed for intubation,10 but can make the difference also for softer activities such as 
neuropsychological testing, psychological support, or logopedic and language training.
Finally, the closure of schools may deprive disabled children of dedicated personalized teaching 
activities in a social and stimulating environment, and we will all pay a higher price in the future. 
We need to massively invest in developing dedicated facilities, human and technological 
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If we take proper action now to grant equal opportunities to neurorehabilitation care, no matter 
what the event causing disability, this emergency will produce long-term healthcare positive 
effects able to prevent, or at least promptly counteract, future outbreaks or their consequences.
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Table 1. Neurorehabilitation in the COVID-19 world
Current challenges and actions to minimize COVID-19 risks in different settings of neurorehabilitation, and possible drawbacks to be overcome 
before continuing on previous healthcare activities.
Challenge Actions Drawbacks
Reduce inpatient and outpatient visits Telerehabilitation and teleconsultations To be made widely available
Not feasible for complex diseases or severe symptoms
Periodic in-person assessments needed
Outpatient and day service Screening for body temperature and active 
respiratory symptoms
Asymptomatic patients are missed
SARS-CoV2 oro-pharyngeal swab and/or 
serological testing, according to local regulations
To be made widely available
Physical distancing Reduced number of simultaneous treatments
Longer opening hours
Caregivers and visitors not allowed to access
Appropriate PPE for operators and patients To be made available at population level
Inpatient Screening for body temperature and active 
respiratory symptoms
Asymptomatic patients are missed
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serological testing on admission, according to 
local regulations
Separate pathways To be considered within hospital re-organization plans
Staff and patient’s protection Personal protective equipment To be made widely available
Robot-assisted rehabilitation To be made widely available
Contact tracing apps Depending on national regulations
Patients with active COVID-19 infection NeuroCOVID-19 wards and/or COVID-19 
hospitals
To be made widely available
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